131 related articles for article (PubMed ID: 1543345)
1. Outcome measures for clinical trials in multiple sclerosis.
Panitch HS
Ann Neurol; 1992 Jan; 31(1):116-7. PubMed ID: 1543345
[No Abstract] [Full Text] [Related]
2. Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.
Simon JH
West J Med; 1996 Jun; 164(6):502-9. PubMed ID: 8764625
[TBL] [Abstract][Full Text] [Related]
3. MRI as an outcome in multiple sclerosis clinical trials.
Tenser RB
Neurology; 2009 Dec; 73(22):1933-4; author reply 1934. PubMed ID: 19949044
[No Abstract] [Full Text] [Related]
4. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
Bar-Zohar D; Agosta F; Goldstaub D; Filippi M
Mult Scler; 2008 Jul; 14(6):719-27. PubMed ID: 18424478
[TBL] [Abstract][Full Text] [Related]
5. Trial measures in multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials.
Paty DW
Neurology; 1988 Jul; 38(7 Suppl 2):82-3. PubMed ID: 3386847
[No Abstract] [Full Text] [Related]
6. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
[TBL] [Abstract][Full Text] [Related]
7. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.
McDonald WI; Miller DH; Thompson AJ
Ann Neurol; 1994 Jul; 36(1):14-8. PubMed ID: 8024255
[No Abstract] [Full Text] [Related]
8. Outcome measures in multiple sclerosis clinical trials.
Andersson PB; Goodkin DE
Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
[TBL] [Abstract][Full Text] [Related]
9. The use of MR imaging as an outcome measure in multiple sclerosis clinical trials.
Bermel RA; Fisher E; Cohen JA
Neuroimaging Clin N Am; 2008 Nov; 18(4):687-701, xi. PubMed ID: 19068409
[TBL] [Abstract][Full Text] [Related]
10. The use of MRI as an outcome measure in clinical trials.
Li DK; Li MJ; Traboulsee A; Zhao G; Riddehough A; Paty D
Adv Neurol; 2006; 98():203-26. PubMed ID: 16400836
[TBL] [Abstract][Full Text] [Related]
11. No shortcuts to outcome in MS clinical trials?
Koch-Henriksen N
Neurology; 2009 Feb; 72(8):686-7. PubMed ID: 19237696
[No Abstract] [Full Text] [Related]
12. MRI as an outcome in multiple sclerosis clinical trials.
Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
[TBL] [Abstract][Full Text] [Related]
13. Methodology of clinical trials in multiple sclerosis.
Mitsikostas DD
Neurol Sci; 2006 Sep; 27 Suppl 5():S362-4. PubMed ID: 16998721
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of follow-up and evolution of multiple sclerosis].
Couvreur G
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1143-51. PubMed ID: 11787348
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in clinical trials.
Ciumas C; Montavont A; Ryvlin P
Curr Opin Neurol; 2008 Aug; 21(4):431-6. PubMed ID: 18607203
[TBL] [Abstract][Full Text] [Related]
16. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history.
Harris JO; Frank JA; Patronas N; McFarlin DE; McFarland HF
Ann Neurol; 1991 May; 29(5):548-55. PubMed ID: 1859184
[TBL] [Abstract][Full Text] [Related]
17. Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials.
Liedtke W; Limmroth V
Ann Neurol; 1996 Feb; 39(2):276-7. PubMed ID: 8967762
[No Abstract] [Full Text] [Related]
18. Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.
Simon JH; Jacobs LD; Campion M; Wende K; Simonian N; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Alam JJ; Fischer JS; Goodkin DE; Granger CV; Lajaunie M; Martens-Davidson AL; Meyer M; Sheeder J; Choi K; Scherzinger AL; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Whitham RH
Ann Neurol; 1998 Jan; 43(1):79-87. PubMed ID: 9450771
[TBL] [Abstract][Full Text] [Related]
19. MRI as an outcome in multiple sclerosis clinical trials.
Sormani MP; Filippi M; De Stefano N; ; Ebers G; Daumer M
Neurology; 2009 Dec; 73(22):1932; author reply 1932-3. PubMed ID: 19949043
[No Abstract] [Full Text] [Related]
20. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
Rovira Cañellas A
Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
